Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Prostate|February 11, 1999
Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of CancerI Rosendahl, G M Kiebert, D Curran, et al.
European Urology|March 31, 1998
Maximal androgen blockade: final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data CenterL J Denis, F Keuppens, P H Smith, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Early adjuvant adriamycin in superficial bladder carcinomaC C Schulman, L J Denis, W Oosterlinck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxelC D Britten, S D Baker, L J Denis, et al.
Acta Chirurgica Belgica|January 1, 1983
[Prostate hypertrophy. Surgical experience in Belgium. Multi-center study of 1,140 patients of 80 years and older]L Denis, W Allegaert, P Auvray, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
European School of Oncology Advisory report to the European Commission for the "Europe Against Cancer Programme" European Code Against CancerP Boyle, U Veronesi, M Tubiana, et al.
Progress in Clinical and Biological Research|January 1, 1984
Early adjuvant adriamycin in superficial bladder carcinomaC C Schulman, L J Denis, W Costerlinck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors. European Organization for Research and Treatment of Cancer Early Clinical Studies GroupF A Eskens, G A Greim, C van Zuylen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancerN C Levitt, F A Eskens, K J O'Byrne, et al.
Pageof 3